Selection bias: maintaining less-differentiated T cells for adoptive immunotherapy.

Area of Science:

• Immunology
• Cancer Biology
• Cellular Therapy

Background:

• Adoptive T cell immunotherapy shows promise but clinical success is limited by the use of mixed T cell populations.
• Preclinical models suggest that purified naive T cells improve persistence and antitumor responses compared to mixed populations.

Purpose of the Study:

• To investigate the interaction between naive and antigen-experienced T cells during adoptive immunotherapy.
• To determine if blocking Fas signaling can improve T cell function and therapeutic efficacy.

Main Methods:

• Utilized preclinical mouse models of melanoma.
• Analyzed Fas-mediated interactions between different T cell subsets.
• Evaluated the impact of Fas signaling blockade on T cell differentiation and antitumor immunity.

Main Results:

• Identified a Fas-mediated interaction driving naive T cell differentiation into less functional states.
• Demonstrated that blocking Fas signaling preserves less-differentiated T cells.
• Showed enhanced antitumor immunity, increased survival, and improved T cell persistence in mice treated with Fas blockade.

Conclusions:

• Naive T cells are essential for optimal adoptive T cell therapy outcomes.
• Fas signaling promotes T cell differentiation, hindering immunotherapy efficacy.
• Targeting Fas signaling represents a novel strategy to enhance adoptive T cell therapy by preserving less-differentiated T cell populations.